Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0200
0.00 (0.00%)
Aug 18, 2025, 4:10 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 16.20 million as of August 19, 2025. Its market cap has increased by 1.40% in one year.
Market Cap
16.20M
Enterprise Value
13.51M
Revenue
4.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 16.20M, a decrease of -92.60%. That is a compound annual growth rate of -38.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 16.20M | 33.42% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | 172.45M | -21.19% |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.92B |
| Pro Medicus | 32.75B |
| Cochlear | 20.21B |
| Sonic Healthcare | 13.99B |
| Ramsay Health Care | 9.01B |
| Telix Pharmaceuticals | 5.92B |
| Ansell | 4.61B |
| Mesoblast | 3.21B |